公开(公告)号：US20130345715A1

公开(公告)日：2013-12-26

申请号：US13692613

申请日：2012-12-03

Applicant: Hanson S. Gifford ,  Mark E. Deem ,  Stephen Boyd

Inventor： Hanson S. Gifford ,  Mark E. Deem ,  Stephen Boyd

IPC: A61B17/22

CPC classification number: A61B18/1492 ,  A61B8/12 ,  A61B17/22012 ,  A61B17/2202 ,  A61B17/221 ,  A61B17/320758 ,  A61B18/02 ,  A61B18/18 ,  A61B2017/22038 ,  A61B2017/22061 ,  A61B2017/22069 ,  A61B2017/22079 ,  A61B2017/22098 ,  A61B2017/2215 ,  A61B2018/00011 ,  A61B2018/0022 ,  A61B2018/0262 ,  A61F2/2445 ,  A61M25/04 ,  A61M2025/105 ,  A61N7/022 ,  A61N2007/0039

Abstract: The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.

Abstract translation: 本发明提供了用于脱钙主动脉瓣的装置和方法。 本发明的方法和装置通过从钙化沉积物中施加或去除热能来分解或消除主动脉瓣内和周围的钙沉积物。

公开(公告)号：US08613749B2

公开(公告)日：2013-12-24

申请号：US10729552

申请日：2003-12-05

Applicant: Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

Inventor： Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

IPC: A61B17/08

CPC classification number: A61B17/1114 ,  A61B17/00234 ,  A61B17/064 ,  A61B17/0644 ,  A61B17/122 ,  A61B2017/00557 ,  A61B2017/306 ,  A61B2090/395 ,  A61F5/0083 ,  A61F5/0086

Abstract: Various obesity treatment tools and methods are described herein, as well as treatments for other gastric-related diseases, e.g., GERD. Treatment includes reducing the size of the stomach pouch to limit the caloric intake as well as to provide an earlier feeling of satiety. This may be done by creating a smaller gastric pouch within the stomach directly from the interior of the stomach itself. The smaller pouches may be made through the use of individual anchoring devices, rotating probes, or volume reduction devices. A pyloroplasty procedure may also be performed to render the pyloric sphincter incompetent. A gastric bypass procedure may additionally be performed using atraumatic magnetic anastomoses devices so that sugars and fats are passed directly to the bowel while bypassing the stomach. Many of these procedures may be done in a variety of combinations. Treatment may create enforced behavioral modifications by discouraging the ingestion of high-caloric foods.

公开(公告)号：US08535301B2

公开(公告)日：2013-09-17

申请号：US13470886

申请日：2012-05-14

Applicant: James L. Cox ,  Stephen W. Boyd ,  Hanson S. Gifford ,  Matthias Vaska

Inventor： James L. Cox ,  Stephen W. Boyd ,  Hanson S. Gifford ,  Matthias Vaska

IPC: A61B18/02

CPC classification number: A61B17/00234 ,  A61B1/042 ,  A61B8/12 ,  A61B17/0057 ,  A61B17/0218 ,  A61B17/0467 ,  A61B17/0469 ,  A61B17/06061 ,  A61B17/2909 ,  A61B17/320016 ,  A61B17/3211 ,  A61B17/3468 ,  A61B18/00 ,  A61B18/02 ,  A61B18/1447 ,  A61B18/1482 ,  A61B18/1492 ,  A61B18/18 ,  A61B18/20 ,  A61B90/37 ,  A61B90/50 ,  A61B2017/00243 ,  A61B2017/00247 ,  A61B2017/00575 ,  A61B2017/00946 ,  A61B2017/0243 ,  A61B2017/047 ,  A61B2017/0472 ,  A61B2017/0474 ,  A61B2017/0475 ,  A61B2017/2931 ,  A61B2017/2943 ,  A61B2017/2945 ,  A61B2017/306 ,  A61B2017/3405 ,  A61B2017/3419 ,  A61B2017/3486 ,  A61B2017/3492 ,  A61B2018/00214 ,  A61B2018/00232 ,  A61B2018/00261 ,  A61B2018/00291 ,  A61B2018/00363 ,  A61B2018/00392 ,  A61B2018/00577 ,  A61B2018/0212 ,  A61B2018/0225 ,  A61B2018/0262 ,  A61B2018/1432 ,  A61B2018/145 ,  A61B2018/1465 ,  A61F2/2427 ,  A61M25/1011 ,  A61M39/0247 ,  A61M2025/028 ,  A61M2039/0252 ,  A61M2039/0276 ,  A61M2039/0279 ,  A61M2205/3344 ,  A61M2205/3355 ,  A61M2205/366 ,  A61N7/02

Abstract: The invention provides surgical systems and methods for ablating heart tissue within the interior and/or exterior of the heart. A plurality of probes is provided with each probe configured for introduction into the chest for engaging the heart. Each probe includes an elongated shaft having an elongated ablating surface of a predetermined shape. The elongated shaft and the elongated ablating surface of each probe are configured to ablate a portion of the heart. A sealing device affixed to the heart tissue forms a hemostatic seal between the probe and the penetration in the heart to inhibit blood loss therethrough.

公开(公告)号：US20130131444A1

公开(公告)日：2013-05-23

申请号：US13618570

申请日：2012-09-14

Applicant: David BOUDREAULT ,  Vivek SHENOY ,  Hanson S. GIFFORD ,  Mark DEEM ,  Michael HENDRICKSEN ,  Doug SUTTON

Inventor： David BOUDREAULT ,  Vivek SHENOY ,  Hanson S. GIFFORD ,  Mark DEEM ,  Michael HENDRICKSEN ,  Doug SUTTON

IPC: A61B17/02 ,  A61F5/01 ,  A61B1/317

CPC classification number: A61B17/025 ,  A61B1/317 ,  A61B17/02 ,  A61B17/0218 ,  A61B17/3421 ,  A61B2017/00115 ,  A61B2017/00557 ,  A61B2017/0212 ,  A61B2017/0225 ,  A61B2017/0275 ,  A61B2017/3488 ,  A61F5/0193 ,  A61M25/0068 ,  A61M25/008 ,  A61M25/0102 ,  A61M25/0147 ,  A61M25/1002 ,  A61M25/1027 ,  A61M2025/0063 ,  A61M2025/0081 ,  A61M2025/0163 ,  A61M2025/1068 ,  A61M2025/1072 ,  A61M2025/1081 ,  A61M2025/1086 ,  A61M2025/1088

Abstract: A method of treating a patient's joint having opposing joint surfaces includes providing an elongate member having a proximal end, a distal end and an expandable member near the distal end. The expandable member is positioned in the joint between the joint surfaces and expanded so as to separate the joint surfaces away from one another into a distracted position. The joint is manipulated while in the distracted position so that the joint is distracted and in flexion. A diagnostic or therapeutic procedure is then performed on the joint while maintaining the joint in the flexed and distracted position.

公开(公告)号：US08419755B2

公开(公告)日：2013-04-16

申请号：US13029075

申请日：2011-02-16

Applicant: Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

Inventor： Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

IPC: A61B17/08

CPC classification number: A61B17/1114 ,  A61B17/00234 ,  A61B17/064 ,  A61B17/0644 ,  A61B17/122 ,  A61B2017/00557 ,  A61B2017/306 ,  A61B2090/395 ,  A61F5/0083 ,  A61F5/0086

Abstract: Various obesity treatment tools and methods are described herein, as well as treatments for other gastric-related diseases, e.g., GERD. Treatment includes reducing the size of the stomach pouch to limit the caloric intake as well as to provide an earlier feeling of satiety. This may be done by creating a smaller gastric pouch within the stomach directly from the interior of the stomach itself. The smaller pouches may be made through the use of individual anchoring devices, rotating probes, or volume reduction devices. A pyloroplasty procedure may also be performed to render the pyloric sphincter incompetent. A gastric bypass procedure may additionally be performed using atraumatic magnetic anastomoses devices so that sugars and fats are passed directly to the bowel while bypassing the stomach. Many of these procedures may be done in a variety of combinations. Treatment may create enforced behavioral modifications by discouraging the ingestion of high-caloric foods.

公开(公告)号：US08357139B2

公开(公告)日：2013-01-22

申请号：US12264849

申请日：2008-11-04

Applicant: Mark E. Deem ,  Hanson S. Gifford, III ,  Ronald French ,  Douglas Sutton

Inventor： Mark E. Deem ,  Hanson S. Gifford, III ,  Ronald French ,  Douglas Sutton

IPC: A61M31/00 ,  A61F2/20 ,  A61B1/12 ,  A62B9/02

CPC classification number: F16K15/147 ,  A61B17/12022 ,  A61B17/12104 ,  A61B17/12131 ,  A61B17/12172 ,  A61B17/221 ,  A61B2017/1205 ,  A61B2017/2215 ,  A61B2090/061 ,  A61F2/04 ,  A61F2/24 ,  A61F2/2403 ,  A61F2/2412 ,  A61F2/2418 ,  A61F2/91 ,  A61F2002/043 ,  A61F2220/0008 ,  A61F2220/0016 ,  A61F2220/005 ,  Y10S128/912

Abstract: Systems, methods and devices for performing pulmonary procedures, and in particular treating lung disease. A flow control element includes a valve that prevents airflow in the inhalation direction but permits airflow in the exhalation direction. The flow control element is guided to and positioned at the site by a bronchoscope that is introduced into the patient's trachea and used to view the lungs during delivery of the flow control element. The valve may include one, two or more valve elements, and it may be collapsible for easier delivery. A source of vacuum or suction may be used to increase the amount of fluid withdrawn from the lung tissue. A device for measuring hollow structures, such as bronchioles, and a device for removing a previously-placed flow control element are disclosed as well.

公开(公告)号：US20120310233A1

公开(公告)日：2012-12-06

申请号：US13509581

申请日：2010-11-11

Applicant: Steven C. Dimmer ,  Martin L. Mayse ,  Mark Deem ,  Hanson S. Gifford, III

Inventor： Steven C. Dimmer ,  Martin L. Mayse ,  Mark Deem ,  Hanson S. Gifford, III

IPC: A61B18/14 ,  A61B18/18

CPC classification number: A61B18/1492 ,  A61B18/1477 ,  A61B2018/00005 ,  A61B2018/00011 ,  A61B2018/0016 ,  A61B2018/00214 ,  A61B2018/0022 ,  A61B2018/00267 ,  A61B2018/00434 ,  A61B2018/00541 ,  A61B2018/1435 ,  A61B2018/1467 ,  A61B2018/1475 ,  A61N7/022 ,  A61N2007/003

Abstract: Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input. The system, delivery devices, and methods can damage tissue and manage scarring and stenosis.

Abstract translation: 系统，输送装置和治疗方法以消融，损伤或以其他方式影响组织。 治疗系统能够递送可消融靶组织的可冷却消融组件，而不损伤非靶组织。 可冷却消融组件损伤神经组织以暂时或永久减少神经系统输入。 系统，输送装置和方法可能会损伤组织并管理瘢痕和狭窄。

公开(公告)号：US20120226269A1

公开(公告)日：2012-09-06

申请号：US13470886

申请日：2012-05-14

Applicant: James L. COX ,  Stephen W. BOYD ,  Hanson S. GIFFORD, III ,  Matthias VASKA

Inventor： James L. COX ,  Stephen W. BOYD ,  Hanson S. GIFFORD, III ,  Matthias VASKA

IPC: A61B18/02

CPC classification number: A61B17/00234 ,  A61B1/042 ,  A61B8/12 ,  A61B17/0057 ,  A61B17/0218 ,  A61B17/0467 ,  A61B17/0469 ,  A61B17/06061 ,  A61B17/2909 ,  A61B17/320016 ,  A61B17/3211 ,  A61B17/3468 ,  A61B18/00 ,  A61B18/02 ,  A61B18/1447 ,  A61B18/1482 ,  A61B18/1492 ,  A61B18/18 ,  A61B18/20 ,  A61B90/37 ,  A61B90/50 ,  A61B2017/00243 ,  A61B2017/00247 ,  A61B2017/00575 ,  A61B2017/00946 ,  A61B2017/0243 ,  A61B2017/047 ,  A61B2017/0472 ,  A61B2017/0474 ,  A61B2017/0475 ,  A61B2017/2931 ,  A61B2017/2943 ,  A61B2017/2945 ,  A61B2017/306 ,  A61B2017/3405 ,  A61B2017/3419 ,  A61B2017/3486 ,  A61B2017/3492 ,  A61B2018/00214 ,  A61B2018/00232 ,  A61B2018/00261 ,  A61B2018/00291 ,  A61B2018/00363 ,  A61B2018/00392 ,  A61B2018/00577 ,  A61B2018/0212 ,  A61B2018/0225 ,  A61B2018/0262 ,  A61B2018/1432 ,  A61B2018/145 ,  A61B2018/1465 ,  A61F2/2427 ,  A61M25/1011 ,  A61M39/0247 ,  A61M2025/028 ,  A61M2039/0252 ,  A61M2039/0276 ,  A61M2039/0279 ,  A61M2205/3344 ,  A61M2205/3355 ,  A61M2205/366 ,  A61N7/02

Abstract: The invention provides surgical systems and methods for ablating heart tissue within the interior and/or exterior of the heart. A plurality of probes is provided with each probe configured for introduction into the chest for engaging the heart. Each probe includes an elongated shaft having an elongated ablating surface of a predetermined shape. The elongated shaft and the elongated ablating surface of each probe are configured to ablate a portion of the heart. A sealing device affixed to the heart tissue forms a hemostatic seal between the probe and the penetration in the heart to inhibit blood loss therethrough.

Abstract translation: 本发明提供了用于消除心脏内部和/或外部的心脏组织的外科系统和方法。 设置有多个探针，每个探针被配置成引入胸部以接合心脏。 每个探针包括具有预定形状的细长烧蚀表面的细长轴。 每个探针的细长轴和细长的烧蚀表面被配置成烧蚀心脏的一部分。 固定在心脏组织上的密封装置在探针和心脏中的穿透之间形成止血密封，以抑制通过其中的失血。

公开(公告)号：US08172827B2

公开(公告)日：2012-05-08

申请号：US11445644

申请日：2006-06-01

Applicant: Mark E. Deem ,  Hanson S. Gifford, III

Inventor： Mark E. Deem ,  Hanson S. Gifford, III

IPC: A61M31/00 ,  A62B9/00

CPC classification number: A61M5/162 ,  A61B1/018 ,  A61B1/04 ,  A61B1/0661 ,  A61B1/2676 ,  A61M5/1452 ,  A61M5/30 ,  A61M11/00 ,  A61M16/00 ,  A61M25/0084 ,  A61M25/10 ,  A61M2025/0086 ,  A61M2025/105 ,  A61M2202/049 ,  A61M2210/1035

Abstract: Apparatus for providing intrabronchial delivery of neurotoxins to control the effects of asthma comprises a shaft having proximal and distal ends and a neurotoxin applicator assembly disposed on the distal end. The neurotoxin applicator assembly comprises a deployable needle assembly, a rotating needle assembly, and a needle-less injection assembly or a nebulizer assembly.

Abstract translation: 用于提供神经毒素的支气管内递送以控制哮喘的作用的装置包括具有近端和远端的轴和设置在远端的神经毒素施用器组件。 神经毒素施用器组件包括可展开针组件，旋转针组件和无针注射组件或喷雾器组件。

公开(公告)号：US08123765B2

公开(公告)日：2012-02-28

申请号：US11757943

申请日：2007-06-04

Applicant: Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

Inventor： Mark E. Deem ,  Douglas S. Sutton ,  Hanson S. Gifford, III ,  Bernard H. Andreas ,  Ronald G. French

IPC: A61B17/08

CPC classification number: A61B17/1114 ,  A61B17/00234 ,  A61B17/064 ,  A61B17/0644 ,  A61B17/122 ,  A61B2017/00557 ,  A61B2017/306 ,  A61B2090/395 ,  A61F5/0083 ,  A61F5/0086

Abstract: Various obesity treatment tools and methods are described herein, as well as treatments for other gastric-related diseases, e.g., GERD. Treatment includes reducing the size of the stomach pouch to limit the caloric intake as well as to provide an earlier feeling of satiety. This may be done by creating a smaller gastric pouch within the stomach directly from the interior of the stomach itself. The smaller pouches may be made through the use of individual anchoring devices, rotating probes, or volume reduction devices. A pyloroplasty procedure may also be performed to render the pyloric sphincter incompetent. A gastric bypass procedure may additionally be performed using atraumatic magnetic anastomoses devices so that sugars and fats are passed directly to the bowel while bypassing the stomach. Many of these procedures may be done in a variety of combinations. Treatment may create enforced behavioral modifications by discouraging the ingestion of high-caloric foods.

Abstract translation: 本文描述了各种肥胖治疗工具和方法，以及用于其它胃相关疾病例如GERD的治疗。 治疗包括减小胃袋的尺寸以限制热量摄入以及提供较早的饱腹感。 这可以通过在胃内部直接从胃内部产生较小的胃袋来完成。 较小的袋可以通过使用单独的锚定装置，旋转探针或体积减小装置来制造。 还可以进行幽门成形术以使幽门括约肌无能力。 另外可以使用无创伤的磁性吻合装置进行胃旁路手术，使得糖和脂肪在绕过胃时直接通过肠。 这些程序中的许多可以以各种组合进行。 治疗可能会通过阻止摄入高热量食物而产生强制行为改变。